Thus, based on the combined results from the gain- and loss-of-function approaches in vivo and in vitro, we concluded that the upregulated TRAF3 expression in hepatocytes functions as a positive regulator of HFD-induced obesity and insulin resistance. The gene discussed is TRAF3; the disease is obesity disorder.